Prophylaxis against Colorectal Cancer

References

• Bülow S. Familial polyposis coli. A clinical and epidemiologial study [Thesis]. København: Lægeforeningens Forlag 1986
   Google Scholar
• Billow S. Familial adenomatous polyposis. Ann Med 1989; 21: 299–307
   PubMedGoogle Scholar
• Bülow S. Diagnosis of familial adenomatous polyposis. World J Surg 1991; 15: 41–6
   PubMedGoogle Scholar
• Bisgaard M L, Fenger K, Bülow S, et al. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Human Mutation 1994; 3: 121–5
   PubMed Web of Science ®Google Scholar
• Maher E R, Barton D E, Slatter R, et al. Evaluation of molecular genetic diagnosis in the management of familial adenomatous polyposis coli: a population based study. J Med Genet 1993; 30: 675–8
   PubMedGoogle Scholar
• Bülow S, Alm T, Fausa O, et al. Duodenal adenomatosis in familial adenomatous polyposis. Int J Colorectal Dis 1995; 10: 43–6
   PubMed Web of Science ®Google Scholar
• De Cosse J J, Bülow S, Neale K, et al. Rectal cancer risk in patients treated for familial adenomatous polyposis. Br J Surg 1992; 79: 1372–5
   PubMedGoogle Scholar
• Nugent K P, Phillips R KS. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern. Br J Surg 1992; 79: 1204–6
   PubMed Web of Science ®Google Scholar
• Madden M V, Neale K, Nicholls R J, et al. Comparison of morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous polyposis. Br J Surg 1991; 78: 789–92
   PubMedGoogle Scholar
• Giardello F M, Hamilton S R, Krush A J, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313–6
   PubMedGoogle Scholar
• Nugent K P, Farmer K CR, Spigelman A D, et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 1618–9
   PubMed Web of Science ®Google Scholar
• Petersen G M, Francomano C, Kinzler K, Nakamura Y. Presymptomatic direct detection of adenomatous polyposis coli (APC) gene mutations in familial adenomatous polyposis. Hum Genet 1993; 91: 307–11
   PubMedGoogle Scholar
• Bülow S, Burn J, Neale K, et al. The establishment of a polyposis register. Int J Colorectal Dis 1993; 8: 34–8
   PubMed Web of Science ®Google Scholar
• Bülow S, Bøndergaard J O, Moesgaard F. Familiær adenomatøs polypose. Ugeskr Læger 1990; 152: 2628–32
   PubMedGoogle Scholar
• Lynch H T, Lanspa S, Smyrk T, et al. Hereditary nonpolyposis Colorectal cancer (Lynch Syndromes I & II). Genetics, pathology, natural history, and cancer control, part I. Cancer Genet Cytogenet 1991; 53: 143–60
   PubMedGoogle Scholar
• The HNPCC Groups in Denmark, Holland and Finland. Hereditary non-polyposis colorectal cancer. Scand J Gastroenterol 1994; 29: 673–7
   PubMedGoogle Scholar
• Vasen H FA, Offerhaus G JA, den Hartog Jager F CA, et al. The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer 1990; 46: 31–4
   PubMed Web of Science ®Google Scholar
• Mecklin J P, Sipponen P, Järvinen H I. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum 1986; 29: 849–53
   PubMed Web of Science ®Google Scholar
• Vasen H FA, Mecklin I-P, Meera Khan P, Lynch H T. The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424–5
   PubMed Web of Science ®Google Scholar
• Peltomäki P, Aaltonen L A, Sistonen P, et al. Science 1993; 260: 810–2
   PubMed Web of Science ®Google Scholar
• Lindblom A, Tannergård P, Werelius B, Nordenskjöld M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 1993; 5: 279–82
   PubMed Web of Science ®Google Scholar
• Papadopoulous N, Nicolaides N C, Wei Y F, et al. Matation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 1625–9
   PubMedGoogle Scholar
• Mecklin J P. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987; 93: 1021–5
   PubMed Web of Science ®Google Scholar
• Kee F, Collins B J. How prevalent is cancer family syndrome?. Gut 1991; 32: 509–12
   PubMed Web of Science ®Google Scholar
• De Leon M P, Sassatelli R, Benatti P, Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population: the 6-year experience of a population-based registry. Cancer 1993; 71: 3493–501
   PubMedGoogle Scholar
• Mecklin J P, Järvinen H. Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 1993; 36: 927–9
   PubMedGoogle Scholar
• Vasen H F, Mecklin J-P, Watson P, et al. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. Dis Colon Rectum 1993; 36: 1–4
   PubMedGoogle Scholar
• Kee F, Collins B J, Patterson C C. Prognosis in familial nonpolyposis colorectal cancer. Gut 1991; 53: 143–60
   Google Scholar
• Myrhøj T, Bernstein I, Bisgaard M L, et al. The establishment of an HNPCC register. Anticancer Research 1994; 14: 1647–50
   PubMedGoogle Scholar
• Lovett E. Familial factors in the etiology of carcinoma of the large bowel. Proc Roy Soc Med 1974; 67: 21–2
   Google Scholar
• Kune G A, Kune S, Watson L F. The Melbourne cancer study. Dis Colon Rectum 1987; 30: 600–6
   PubMedGoogle Scholar
• Rozen P, Lynch H T, Figer A, et al. Familial colon cancer in the Tel-Aviv area and the influence of ethnic origin. Cancer 1987; 60: 2355–9
   PubMedGoogle Scholar
• Søndergaard J O, Bülow S, Lynge E. Cancer incidence among parents of patients with colorectal cancer. Int J Cancer 1991; 37: 202–6
   Google Scholar
• Mellemgaard A, Møller Jensen O, Lynge E. Cancer incidence among spouses of patients with colorectal cancer. Int J Cancer 1989; 44: 225–8
   PubMedGoogle Scholar
• Luchtefeld M A, Syverson D, Solfelt M, et al. Is colonoscopic screening appropriate in asymptomatic patients with family history of colon cancer?. Dis Colon Rectum 1991; 34: 763–8
   PubMedGoogle Scholar
• Sauar J, Hausken Y, Hoff G, et al. Colonoscopic screening examination of relatives of patients with colorectal cancer. Scand J Gastroenterol 1992; 27: 661–6
   PubMed Web of Science ®Google Scholar
• Rozen P, Fireman Z, Figer A, et al. Family history of colorectal cancer as a marker of potential malignancy within a screening program. Cancer 1987; 60: 248–54
   PubMedGoogle Scholar
• Cannon-Albright L A, Skolnick M H, Timothy Bishop D, et al. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988; 319: 533–7
   PubMed Web of Science ®Google Scholar
• Dunlop M G. Screening for large bowel neoplasms in individuals with a family history of colorectal cancer. Br J Surg 1992; 79: 488–94
   PubMedGoogle Scholar
• Eddy D M, Nugent F W, Eddy J F, et al. Screening for colorectal cancer in a high risk population: results of a mathematical model. Gastroenterology 1987; 92: 682–92
   PubMed Web of Science ®Google Scholar
• Burt R W, Bishop D T, Lynch H T, et al. Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Bulletin OMS 1990; 68: 655–65
   PubMed Web of Science ®Google Scholar
• Mandel J S, Bond J H, Church T R, Snover D C, Bradley G M, Schuman L M, Ederer F for the Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365–71
   PubMed Web of Science ®Google Scholar
• Røseth A G, Kristinsson J, Fagerhol M K, Schønsby H, Aadland E, Nygaard K, Roald B. Fecal calprotectin: a novel test for the diagnosis of colorectal cancer?. Scand J Gastroenterol 1993; 28: 1073–6
   PubMed Web of Science ®Google Scholar
• Kronborg O. Population screening for colorectal cancer, the goals and means. Ann Med 1991; 23: 373–9
   PubMed Web of Science ®Google Scholar
• Atkin W S, Cuzick J, Northover J MA, Whynes D K. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341: 736–40
   PubMed Web of Science ®Google Scholar
• Kronborg O, Jørgensen O D, Fenger C. Advantages and drawbacks of adding flexible 60 cm sigmoidoscopy to Hemoccult-II in screening for colorectal neoplasia [Abstract]. The 3rd United European Gastroenterology Week. Oslo, Norway June, 1994; A41
   Google Scholar
• Kronborg O. Screening for colorectal neoplasia—review and recommendations. Ugeskr Laeger 1993; 155: 3272–7
   PubMedGoogle Scholar
• Kionborg O. Faecal occult blood tests in adenoma detection. Eur J Cancer Prevention 1993; 2(Suppl 2)107–10
   PubMedGoogle Scholar
• Jørgensen O D, Kronborg O, Fenger C. The Funen adenoma follow-up study. Characteristics of patients and initial adenomas in relation to severe dysplasi. Scand J Gastroenterol 1993; 28: 239–43
   PubMed Web of Science ®Google Scholar
• Winaver S J, O'Brien M J, Way J D, Kronborg O, Bond J, Frühmorgen P, , WHO Collaborating Centre for the Prevention of Colorectal Cancer, et al. Risk and surveillance of individuals with colorectal polyps. Bull WHO 1990; 68: 789–95
   PubMedGoogle Scholar
• Jørgensen O D, Kronborg O, Fenger C. The Funen adenoma follow-up study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993; 28: 869–74
   PubMed Web of Science ®Google Scholar
• Winawer S K, Zauber Ann G, Ho M N, O'Bruen M J, Gottleib L S, Sternberg S S, et al. National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977–81
   PubMed Web of Science ®Google Scholar
• Kronborg O. The Funen adenoma follow-up study. Proceedings of an international meeting organized by the United Kingdom Co-ordinating Committee on Cancer Research: Screening for Colorectal Cancer., J D Hardcastle. Normed Verlag, Hamburg 1089; 38–43
   Google Scholar
• Faivre J, Boutron M C, Doyon F, Pigtanelli M, Kronborg O, Giacosa A, ECP Colon Group. The ECP calcium fibre polyp prevention study preliminary report. Eur J Cancer Prevention 1993; 2(Suppl 2)99–106
   PubMedGoogle Scholar
• Olsen J, Kronborg, Lynggaard J, Ewertz M. Dietary risk factors for cancer and adenomas of the large intestine. A case-control study within a screening trial in Denmark, Eur J Cancer 1994; 30A: 53–60
   Google Scholar
• Winaver S J, Zauber A G, O'Brien M J, Ho M N, Gottlieb L, Sternberg S S, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Group. N Engl J Med 1993; 328: 901–6
   PubMedGoogle Scholar
• Cali R L, Pitsch R M, Thorson A G, Watson P, Tapia P, Blatchford G J, Christensen M A. Cumulative incidence of metachronous colorectal cancer. Dis Col Rectum 1993; 36: 388–93
   PubMedGoogle Scholar
• Kronborg O, Hage E, Fenger C, Deichgraeber E. Do synchronous adenomas influence prognosis after radical surgery for colorectal carcinoma? A prospective study. Int J Col Dis 1986; 1: 99–103
   PubMedGoogle Scholar
• Kronborg O, Fenger C, Deichgraeber E, Hansen L. Follow-up after radical surgery for colorectal cancer; design of a randomized study. Scand J Gastroennterol 1988; 149 Suppl: 159–62
   Google Scholar
• Kronborg O, Fenger C, Deichgraeber E. Colonoscopy after radical surgery for colorectal cancer. A ten-year prospective investigation of 309 patients. Ugeskr Laeger 1991; 153: 503–6
   PubMedGoogle Scholar
• Jahn H, Jørgensen O D, Kronborg O, Fenger C. Can Hemoccult-IITM replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy?. Dis Col Rect 1992; 35: 253–6
   PubMed Web of Science ®Google Scholar
• Hall C, Griffin J, Dykes P W, Williams J A, Keighly M R. Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer. Gut 1993; 34: 227–29
   PubMedGoogle Scholar
• Northover J MA. Carcinoembryonic antigen and recurrent colorectal cancer. Br J Surgery 1985; 72 Suppl: 44–6
   Google Scholar